Материалов:
1 082 141

Репозиториев:
30

Авторов:
761 409

расширенный поиск

Angiotensin-receptor neprilysin inhibitor LCZ696; A novel therapy for heart failure

Mohammad B.I., Hadi N.R., Singh R.B., Shastun S., Sharmanov T., Tazhibayev S., Gumarova L.

Дата публикации в реестре: 2020-03-03T14:40:19Z

Аннотация:
Ключевые слова:
angiotensin receptor, carnitine, enalapril, eplerenone, hydralazine plus isosorbide dinitrate, membrane metalloendopeptidase, omega 3 fatty acid, sacubitril plus valsartan, ubidecarenone, valsartan, Article, atrial fibrillation, cardiovascular mortality, cardiovascular risk, clinical feature, diabetes mellitus, drug efficacy, drug mechanism, food and drug administration, heart ejection fraction, heart failure, heart left ventricle ejection fraction, heart left ventricle wall, heart volume, hospitalization, human, kidney function, morbidity, New York Heart Association class, nutritional deficiency, phase 2 clinical trial (topic), randomized controlled trial (topic), renin angiotensin aldosterone system, systolic blood pressure

Тип: Article

Права: open access

Источник: World Heart Journal

Другие версии документа

Angiotensin-receptor neprilysin inhibitor LCZ696; a novel therapy for heart failure

Связанные документы (рекомендация CORE)

Партнеры

КФУ
ТГУ
Elpub
СФУ
Webpublishers

Индексация

BASE
WorldCat
OpenAIRE
EDS
core